January 22, 2018 / 6:00 PM / Updated 4 minutes ago BRIEF-Pulmatrix Announces Acceptance Of A Clinical Trial Application In Europe For Pulmazole Reuters Staff 1 Min Read 
Jan 22 (Reuters) - Pulmatrix Inc: 
* PULMATRIX ANNOUNCES ACCEPTANCE OF A CLINICAL TRIAL APPLICATION IN EUROPE FOR PULMAZOLE - AN INHALED DRY-POWDER ISPERSEâ„¢ FORMULATION OF ITRACONAZOLE 
* PULMATRIX INC - EXPECTS THAT TOP LINE RESULTS FOR PUR1900 STUDY WILL BE AVAILABLE IN MID-2018 Source text for Eikon: Further company coverage: